Stock screener

BMRA

Conviction 0HealthcareScan · Mon, Aug 10, 2026
BMRA$1.63+1.24%
ResistanceSupportVol 14
63 bars
Vol MA14 6.43K
May 11May 28Jun 16Jul 6Jul 23Aug 10
BIOMERICA INCIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.biomerica.com
Price1.63
Change+1.24%
Gap+4.35%
Rel volume0.10×
Avg volume6.21K
Avg $ vol9.85K
SMA 201.60
SMA 501.79
SMA 2002.21
Price vs 50-8.73%
Price vs 200-26.08%
MA stackbearish
50/200 cross
Supertrenddown · 1.72
RSI (14)47
MACD hist0.02
MACD cross
Stoch %K / %D78 / 74
ADX (14)21
+DI / −DI23 / 23
RSI divergence
MACD divergenceBullish
ATR %+4.54%
ADR %3.41%
52w high3.51
52w low1.49
From 52w high-53.56%
Above 52w low+9.40%
New 52w highNo
SqueezeOn · 6d
Bollinger width10.15%
%B0.70
Donchian pos69.23%
Donchian high1.71
Donchian low1.45
AVWAP (52w high)3.47
vs AVWAP high-53.06%
AVWAP (52w low)1.54
vs AVWAP low+6.12%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d0.10×
Avg vol (14d)6.43K
Avg vol (20d)6.21K
Avg $ vol (20d)9.85K
Market cap5.04M
RS 3m (vs SPY)-32.35%
RS 6m (vs SPY)-43.19%
RS line new highNo
Trend template0/8
Technical rank17.2
1 week+6.54%
1 month-3.55%
3 months-26.58%
6 months-27.56%
1 year-47.59%
YTD-35.57%
P/E-1.01
P/B1.52
P/S0.95
P/FCF-1.29
EPS-2.16
Div yield
ROE-149.92%
ROA-101.95%
Debt/Eq
Current2.64
EV/EBITDA-0.73
Gross margin9.38%
Net margin-93.64%
Rev growth-1.92%
EPS growth16.81%
Price target
Target upside
Analyst rating
Institutional
Ent. value3.7M
Revenue987K
Net income-1.31M
Gross profit-44K
Free cash flow-3.89M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out3.09M
Employees54
ListedTue, Sep 26, 1978
Free float2.5M
Float %82.8%
Short interest22.06K
Days to cover3.1d
Short volume22.9%
Squeeze score18 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank17.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance1.96
Support1.45
Days since event
Candle confirm
News sentiment

Financials as of Sat, Feb 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BMRA

All disclosures →
No recent disclosed trades by Congress in BMRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BMRA

No recent insider (Form 4) filings in BMRA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BMRA · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.